As of November 7, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Biovie Inc. The largest reported stake is Morgan Stanley's, at 11.9%. 6 filings are on record since March 25, 2026 (Schedule 13G/A, August 7, 2026).
Sell to companies like Biovie Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Jane Street Group, LLC · Sole voting: 0 · Shared voting: 230,662 · Sole dispositive: 0 · Shared dispositive: 230,662 · SCHEDULE 13G/A, 2026-11-06
- · Holder: Jane Street Group, LLC · Percent: 5.2% · SCHEDULE 13G
- · Reporting person: Alta Partners LLC · Sole voting: 687,321 · Shared voting: 0 · Sole dispositive: 687,321 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-19
- · Reporting person: Morgan Stanley · Sole voting: 0 · Shared voting: 1 · Sole dispositive: 0 · Shared dispositive: 896,822 · SCHEDULE 13G/A, 2026-08-07
- · Holder: Morgan Stanley · Percent: 8% · SCHEDULE 13G
Biovie Inc. has 6 Schedule 13D or 13G filings on record since 2026-03-25. 3 holders' latest filing reports 5% or more of class a common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 11.9% | 896,822 | SCHEDULE 13G/A, 2026-08-07 | 2026-07-31 | |
| Alta Partners LLC | 8.4% | 687,321 | SCHEDULE 13G, 2026-08-19 | 2026-08-12 |
| 5.03% | 399,018 | SCHEDULE 13D, 2026-03-25 | 2026-01-05 | |
| Jane Street Group, LLC | 2.7% | 230,662 | SCHEDULE 13G/A, 2026-11-06 | 2026-09-30 |
Holding shares or following this stake? See who's behind Biovie Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Biovie Inc. and the records around it.
Biovie Inc. elsewhere on the record
Companies that share a holder
- Alta Partners LLC also filed stake reports on 26 other companies: Robin Energy Ltd. (Oct 2026), Huachen AI Parking Management Technology Holding Co., Ltd (Oct 2026), C3is Inc. (Oct 2026)
- JANE STREET GROUP, LLC also filed stake reports on 73 other companies: AXT INC (Nov 2026), Bitdeer Technologies Group (Nov 2026), Bloom Energy Corp (Nov 2026)
- Morgan Stanley also filed stake reports on 182 other companies: MDA Space Ltd. (Nov 2026), RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. (Oct 2026), Arbutus Biopharma Corp (Oct 2026)
Watch Biovie Inc.
Get an email when Biovie Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Biovie Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Biovie Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Biovie Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Morgan Stanley | 0 | 1 | 0 | 896,822 | SCHEDULE 13G/A, 2026-08-07 |
| Morgan Stanley Smith Barney LLC | 0 | 1 | 0 | 896,822 | SCHEDULE 13G/A, 2026-08-07 |
| Alta Partners LLC | 687,321 | 0 | 687,321 | 0 | SCHEDULE 13G, 2026-08-19 |
| Jane Street Group, LLC | 0 | 230,662 | 0 | 230,662 | SCHEDULE 13G/A, 2026-11-06 |
| Jane Street Capital, LLC | 0 | 2,374 | 0 | 2,374 | SCHEDULE 13G/A, 2026-11-06 |
| Jane Street Global Trading, LLC | 0 | 228,288 | 0 | 228,288 | SCHEDULE 13G/A, 2026-11-06 |
The latest filing identifies Biovie Inc. by CUSIP 09074F504 and gives its principal executive office as 680 W NYE LANE, CARSON CITY, NV 89703 (SCHEDULE 13G/A, 2026-11-06).
Purpose of Transaction (Item 4)
Do Cuong V
The Reporting Persons acquired all their securities for investment purposes only and the securities are being held as a long-term investment. The Reporting Persons intend to continuously review their investment in the Issuer and may in the future determine to acquire additional securities of the Issuer or dispose of the securities of the Issuer owned by them or take any other available course of action, including surrendering or selling shares back to the Issuer for tax withholding obligations. Notwithstanding anything contained herein, the Reporting Persons specifically reserve the right to change their intention with respect to any or all of such matters. Mr. Do is the President and Chief Executive Officer of the Issuer and acquired his securities in that capacity. As a result, Mr. Do may have influence over the corporate activities of the Issuer, including activities that may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Other than as described above, the Reporting Persons do not have any present plans or proposals as of the date hereof that relate to or would result in any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. However, as part of ongoing evaluation of their investment and investment alternatives, each Reporting Person may consider such matters and, subject to applicable law, may formulate a plan or proposal with respect to such matters, and, from time to time, may hold …The first part of Item 4 of the SCHEDULE 13D filed 2026-03-25; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-03-25 | Do Cuong V | 5.03% | SCHEDULE 13D |
| 2026-08-07 | Morgan Stanley | 8% | SCHEDULE 13G |
| 2026-08-07 | Morgan Stanley | 11.9% | SCHEDULE 13G/A |
| 2026-08-19 | Alta Partners LLC | 8.4% | SCHEDULE 13G |
| 2026-09-03 | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-11-06 | Jane Street Group, LLC | 2.7% | SCHEDULE 13G/A |
Questions about who owns Biovie Inc.
Who owns Biovie Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Biovie Inc.: Morgan Stanley (11.9%, Schedule 13G/A, filed 2026-08-07), Alta Partners LLC (8.4%, Schedule 13G, filed 2026-08-19) and Do Cuong V (5.03%, Schedule 13D, filed 2026-03-25).
Who are the largest shareholders of Biovie Inc.?
By the share each holder's latest filing reports, the largest holders of Biovie Inc. on this page are Morgan Stanley (11.9%), Alta Partners LLC (8.4%) and Do Cuong V (5.03%).
When did Morgan Stanley buy into Biovie Inc.?
The filings give report dates, not purchase dates. The earliest filing from Morgan Stanley on this page is the Schedule 13G, filed 2026-08-07, reporting 8%; its latest, Schedule 13G/A filed 2026-08-07, reports 11.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Biovie Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.